In developing countries, many newborns pass away because they are exposed to germs and pathogens that cause infection. In fact, about a quarter of all newborn deaths are due to infections. However, a new medicine called chlorhexidine (CHX) has been proven very effective in preventing infection, also called newborn sepsis. Last week, a group of practitioners gathered in Washington, D.C. to discuss countries’ progress in introducing and scaling up the use of CHX, and the way forward. I was honored to be part of this group.